貸倒引当金繰入額、売上原価、減価償却費 - その他他1件
- 【期間】
| 年度 | 貸倒引当金繰入額 | 売上原価 | 減価償却費 - その他 | 資産の部 - ドラッグ・ファーマシー |
|---|
| 2009/02 | 295億 | | 3.37兆 | | - | | - | |
| 2010/02 | 322億 | +9.1% | 3.27兆 | -3.1% | - | | - | |
| 2011/02 | 316億 | -1.9% | 3.32兆 | +1.6% | - | | - | |
| 2012/02 | 237億 | -24.9% | 3.39兆 | +2.1% | - | | - | |
| 2013/02 | 186億 | -21.6% | 3.7兆 | +8.9% | 35.7億 | | - | |
| 2014/02 | 281億 | +50.9% | 4.1兆 | +11% | 36.6億 | +2.5% | - | |
| 2015/02 | 362億 | +29.1% | 4.53兆 | +10.3% | 42.2億 | +15.3% | 2771億 | |
| 2016/02 | 422億 | +16.5% | 5.27兆 | +16.4% | 3.68億 | -91.3% | 2770億 | -0% |
| 2017/02 | 436億 | +3.2% | 5.25兆 | -0.4% | 6.83億 | +85.6% | 2953億 | +6.6% |
| 2018/02 | 456億 | +4.7% | 5.33兆 | +1.5% | 3.91億 | -42.8% | 3377億 | +14.3% |
| 2019/02 | 501億 | +9.9% | 5.39兆 | +1.3% | 5.55億 | +41.9% | - | |
| 2020/02 | 644億 | +28.6% | 5.43兆 | +0.7% | 76.1億 | 大幅増 | - | |
| 2021/02 | 701億 | +8.8% | 5.51兆 | +1.4% | 84.7億 | +11.2% | - | |
| 2022/02 | 484億 | -30.9% | 5.54兆 | +0.6% | 82.7億 | -2.4% | - | |
| 2023/02 | 598億 | +23.4% | 5.73兆 | +3.4% | 83.9億 | +1.6% | - | |
| 2024/02 | 710億 | +18.7% | 5.95兆 | +4% | 101億 | +20.4% | - | |
